Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 11 recruiting now full pipeline

Pelvic Pain: full-pipeline trial registry

11 of 24 indexed Pelvic Pain trials are currently recruiting.

Corpus placement: #686 of 28,707 conditions by registered trial count.

24 US clinical trials · 11 currently recruiting · #686 of 28,707 conditions by registered trial count

Pelvic Pain: 24 US clinical trials tracked, 11 recruiting.

Pelvic Pain is the subject of 24 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Corewell Health East, running 2 of these trials.

Enrollment posture brief

Registry condition pelvic-pain

OPEN 11 | RECR 46% | LATE 4 | EARLY 4 | RANK #686 | SPON 2

Nearest open-share peer: Glaucoma Open-Angle (46% recruiting · 24 trials)

Pelvic Pain (this)46%Aplastic Anemia37.5%Behavior37.5%Allergic Rhinitis8.3%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Pelvic Pain

Pelvic Pain lists 11 open slots (46% of 24 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pelvic Pain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pelvic Pain is recruiting above its size-band peers.

    11 of 24 indexed trials (45.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Pelvic Pain trials is spread across many organizations.

    Corewell Health East accounts for 2 of 24 trials (8.3%). 21 distinct sponsors appear on at least one study for this condition label.

  3. Typical Pelvic Pain enrolment sits around 74 participants.

    Median target enrolment is 74 among the 24 trials that report a genuine target (sentinel values excluded). 14 of those (58.3%) plan for fewer than 100 participants.

  4. Pelvic Pain research is mostly interventional.

    19 interventional and 5 observational studies make up this index (79.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 23Phase 32Phase 42

Open and recent trials

24 total, page 1 of 1

RECRUITING NA 1,650 participants

Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study

Stanford University

NCT05612750

RECRUITING Phase 4 600 participants

NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)

Endeavor Health

NCT06861920

RECRUITING Phase 3 130 participants

Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain

University of Michigan

NCT07100782

RECRUITING 120 participants

Endometriosis Pain

Washington University School of Medicine

NCT06101303

RECRUITING NA 64 participants

Acupuncture for Chronic Pelvic Pain

David Moss

NCT06388590

RECRUITING NA 60 participants

Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain

Washington University School of Medicine

NCT06549985

RECRUITING NA 60 participants

VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia

Medstar Health Research Institute

NCT06840314

RECRUITING NA 40 participants

Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices

Weill Medical College of Cornell University

NCT06168058

RECRUITING 30 participants

Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization

University of Kansas Medical Center

NCT03794466

RECRUITING NA 20 participants

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

Indiana University

NCT06059586

RECRUITING Phase 2 14 participants

Glycemic Regulation as Endometriosis Adjunct Treatment

Boston Children's Hospital

NCT06611501

ACTIVE NOT RECRUITING 2,000 participants

The Women's Health Study: From Adolescence to Adulthood

Boston Children's Hospital

NCT01738204

COMPLETED 2,923 participants

The Women's Urology Center/WISH Database Project

Corewell Health East

NCT00379002

COMPLETED Phase 3 194 participants

Medical Treatment of Endometriosis-Associated Pelvic Pain

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NCT00229996

COMPLETED NA 120 participants

POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound

Lifespan

NCT02923245

COMPLETED 114 participants

Transvaginal Pelvic Ultrasound in the ED

Hennepin Healthcare Research Institute

NCT02547857

COMPLETED NA 100 participants

Surgical Success After Laparoscopic vs Abdominal Hysterectomy

University of Texas Southwestern Medical Center

NCT01793584

COMPLETED Phase 2 90 participants

Study of U101 for Bladder Pain and/or Urgency

Urigen

NCT00256542

COMPLETED Phase 4 74 participants

Tenaculum Pain Control Study

Oregon Health and Science University

NCT01421641

COMPLETED NA 54 participants

Neurophysiological Effects on tPCS and tDCS on Healthy Subjects and on Patients With Chronic Visceral Pain

Spaulding Rehabilitation Hospital

NCT02497196

COMPLETED Phase 1 50 participants

Endometriosis : Traditional Medicine vs Hormone Therapy

National Center for Complementary and Integrative Health (NCCIH)

NCT00034047

COMPLETED NA 16 participants

Program to Overcome Pelvic Pain With Yoga

University of California, San Francisco

NCT02261740

COMPLETED NA 14 participants

Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)

Kenneth Peters, MD

NCT01731470

COMPLETED Phase 2 10 participants

Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC

Corewell Health East

NCT00420550

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 3
Phase 3 2
Phase 4 2

Named interventions

Most-linked intervention names on Pelvic Pain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
Liposomes Biological
1 trials
Topical Lidocaine Gel Drug
1 trials
Intracervical Lidocaine Injection Drug
1 trials
Alkalinized Lidocaine-Heparin Drug
1 trials
Sham tPCS Device
1 trials
Active tPCS Device
1 trials
Depot-Leuprolide/Norethindrone Drug
1 trials

US sites by state

Facility locations filed on Pelvic Pain trials. A trial with sites in several states counts in each.

Michigan 5 trials
Massachusetts 4 trials
California 3 trials
Pennsylvania 2 trials
Oregon 2 trials
New York 2 trials
North Carolina 2 trials
Missouri 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pelvic Pain page

24 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pelvic Pain condition card totals 24 registered trials; most-linked intervention Placebo; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.